Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients

• Published in: Journal of the Formosan Medical Association Vol. 118; no. 1; pp. 429 - 435
• Main Authors: Cheng, Shih-Lung, Lin, Ching-Hsiung, Wang, Chin-Chou, Chan, Ming-Cheng, Hsu, Jeng-Yuan, Hang, Liang-Wen, Perng, Diahn-Warng, Yu, Chong-Jen, Wang, Hao-Chien
• Format: Journal Article
• Language: English
• Published: Singapore Elsevier B.V 01.01.2019; Elsevier
• Subjects: Adult; Aged; Area Under Curve; CAT; Comorbidity; COPD; Cross-Sectional Studies; Dyspnea - diagnosis; Dyspnea - physiopathology; Female; Forced Expiratory Volume; GOLD guideline; Humans; Lung - physiopathology; Male; Middle Aged; mMRC; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive - diagnosis; Pulmonary Disease, Chronic Obstructive - physiopathology; ROC Curve; Severity of Illness Index; Surveys and Questionnaires; Symptom Assessment - standards; Taiwan; Vital Capacity; Taiwan; GOLD guideline; mMRC; CAT; COPD
• ISSN: 0929-6646; 1876-0821
• DOI: 10.1016/j.jfma.2018.06.018

The 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) proposed a new severity assessment system for emphasizing clinical symptom evaluation by COPD Assessment Test (CAT) or modified Medical Research Council (mMRC) dyspnea scores. The aim of the study was to evaluate the effectiveness of two scoring systems in evaluating COPD patients. A population based cross-sectional study employing computer-assisted telephone interviewing system (CATI) for surveying the epidemiology of COPD in Taiwan. Among 6600 subjects recruited (age > 40), 404 subjects (6.1%) were diagnosed as COPD. The comorbidities, COPD-related symptoms, health care resources utilization were compared between CAT and mMRC. There were significant differences in all co-morbidities, symptom severity in favor of CAT as compared to mMRC. When comparing health care resources utilization, CAT and mMRC have equal effectiveness in evaluating patients with regular medical treatment. There were significant differences in emergency room visit and hospitalization in favor of mMRC. However, CAT was more effective in evaluating patients with ICU admission (P = 0.005). Compared with CAT and mMRC, there are individual benefits in the evaluation of clinical symptoms, co-morbidities and medical resources utilization for ER, hospitalization and ICU admission in COPD patients.